Sarah Hoosdally
Dr
NDM Head of Research Delivery
Sarah joined NDM Strategic in March 2021 having spent 5 years as a Programme Manager in Modernising Medical Microbiology research group. Working closely with the Head of Department and Associate Head of Department she plays a strategic role in the management and development of the strategic research plans of Insitutites, Centres Units and Facilities within NDM. This includes facilitation, contracting, financial planning and risk management, and sits at the interface between science and administration.
Prior to this Sarah worked as a Reserach Contract Specialist in Research Services and completed a post-doc in the Porcher group at the WIMM.
Recent publications
-
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
Journal article
Eyre DW. et al, (2021), Clinical Microbiology and Infection, 27, 1516.e7 - 1516.e14
-
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Journal article
Wei J. et al, (2021), Nature Microbiology, 6, 1140 - 1149
-
Genomic network analysis of environmental and livestock F-type plasmid populations
Journal article
Matlock W. et al, (2021), The ISME Journal, 15, 2322 - 2335
-
GenomegaMap: Within-Species Genome-Wide dN/dS Estimation from over 10,000 Genomes
Journal article
Wilson DJ. et al, (2020), Molecular Biology and Evolution, 37, 2450 - 2460
-
The impact of sequencing depth on the inferred taxonomic composition and AMR gene content of metagenomic samples
Journal article
Gweon HS. et al, (2019), Environmental Microbiome, 14